Elevated antidrug antibodies against atezolizumab and associated clinical outcomes in advanced non-small-cell lung cancer
Miran Jang, Chan Kim, So Jung Kong, Hannah Yang, Won Suk Lee, Ho Yun Lee, Hong Jae Chon, Se‐Hoon Lee
Cancer Immunology Immunotherapy
초록
High ADA levels were linked to lower atezolizumab exposure and worse outcomes. ADA monitoring may help predict prognosis and guide immunotherapy strategies.